BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15691312)

  • 41. Randomized comparison of two rescue therapies for Helicobacter pylori infection.
    Wu DC; Hsu PI; Chen A; Lai KH; Tsay FW; Wu CJ; Lo GH; Wu JY; Wu IC; Wang WM; Tseng HH
    Eur J Clin Invest; 2006 Nov; 36(11):803-9. PubMed ID: 17032348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
    Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
    Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
    Mirbagheri SA; Hasibi M; Abouzari M; Rashidi A
    World J Gastroenterol; 2006 Aug; 12(30):4888-91. PubMed ID: 16937475
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [First line therapy for Helicobacter pylori eradication in France].
    Dupas JL
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):467-72. PubMed ID: 12700504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
    Avsar E; Kalayci C; Tözün N; Lawrence R; Kiziltas S; Gültekin O; Ulusoy NB
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):449-52. PubMed ID: 8804873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
    Francavilla R; Lionetti E; Castellaneta SP; Magistà AM; Boscarelli G; Piscitelli D; Amoruso A; Di Leo A; Miniello VL; Francavilla A; Cavallo L; Ierardi E
    Gastroenterology; 2005 Nov; 129(5):1414-9. PubMed ID: 16285942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
    Cai W; Zhou L; Ren W; Deng L; Yu M
    Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The efficacy of furazolidone-based quadruple therapy for eradication of Helicobacter pylori infection in Iranian patients resistant to metronidazole-based quadruple therapy.
    Ebrahimi-Dariani N; Mirmomen S; Mansour-Ghanaei F; Noormohammadpoor P; Sotodehmanesh R; Haghpanah B; Bahrami H
    Med Sci Monit; 2003 Aug; 9(8):PI105-8. PubMed ID: 12942042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori.
    Taylor JL; Zagari M; Murphy K; Freston JW
    Arch Intern Med; 1997 Jan; 157(1):87-97. PubMed ID: 8996045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea.
    Chung KH; Lee DH; Jin E; Cho Y; Seo JY; Kim N; Jeong SH; Kim JW; Hwang JH; Shin CM
    Gut Liver; 2014 Nov; 8(6):605-11. PubMed ID: 25368747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
    Calvet X; Ducons J; Guardiola J; Tito L; Andreu V; Bory F; Guirao R;
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1261-7. PubMed ID: 12144575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of pretreatment on cure rates of Helicobacter pylori eradication.
    Janssen MJ; Laheij RJ; Jansen JB; de Boer WA
    Neth J Med; 2004 Jun; 62(6):192-6. PubMed ID: 15460498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
    Gessner BD; Bruce MG; Parkinson AJ; Gold BD; Muth PT; Dunaway E; Baggett HC
    Clin Infect Dis; 2005 Nov; 41(9):1261-8. PubMed ID: 16206100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication.
    Chuang CH; Sheu BS; Kao AW; Cheng HC; Huang AH; Yang HB; Wu JJ
    Hepatogastroenterology; 2007; 54(73):320-4. PubMed ID: 17419283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of Helicobacter pylori infection.
    Miehlke S; Bayerdörffer E; Graham DY
    Semin Gastrointest Dis; 2001 Jul; 12(3):167-79. PubMed ID: 11478749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
    Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.